Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients
NCT ID: NCT01370291
Last Updated: 2012-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
60 participants
INTERVENTIONAL
2011-06-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Repetitive Transcranial Magnetic Stimulation in Schizophrenia
NCT03736291
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia
NCT00783120
A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia
NCT03273439
Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.
NCT02842034
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations
NCT02863094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
active Risperidone and active rTMS
active Risperidone and active rTMS for the first-episode schizophrenia patients
active Risperidone and active rTMS
active Risperidone:------- active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC) negative symptoms:high-frequency（10Hz）applied over the left temporoparietal cortex(LTPC)
active rTMS and sham Risperidone
active rTMS and sham Risperidone for the first-episode schizophrenia
active rTMS and sham Risperidone
active Risperidone:------- ; active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC); negative symptoms:high-frequency（10Hz）applied over the left temporoparietal; cortex(LTPC)
sham rTMS and active Risperidone
sham rTMS and active Risperidone for the first-episode schizophrenia patients
sham rTMS and active Risperidone
active Risperidone:------- ; active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC); negative symptoms:high-frequency（10Hz）applied over the left temporoparietal; cortex(LTPC)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
active Risperidone and active rTMS
active Risperidone:------- active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC) negative symptoms:high-frequency（10Hz）applied over the left temporoparietal cortex(LTPC)
active rTMS and sham Risperidone
active Risperidone:------- ; active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC); negative symptoms:high-frequency（10Hz）applied over the left temporoparietal; cortex(LTPC)
sham rTMS and active Risperidone
active Risperidone:------- ; active rTMS:auditory hallucinations:low-frequency(1Hz)applied over the left temporoparietal cortex(LTPC); negative symptoms:high-frequency（10Hz）applied over the left temporoparietal; cortex(LTPC)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of schizophrenia according to DSM-IV criteria(by a board-certified psychiatrist)
* PANSS\>=60
* First episode, and the patients haven't use any antipsychotic drugs
Exclusion Criteria
* Diagnose of substance abuse/dependance
* Severe uncontrolled organic disease that may interfere in the patient´s participation in the study
* Contraindication to TMS:
1. Implanted pacemaker
2. Medication pump
3. Vagal stimulator
4. Deep brain stimulator
5. Metallic hardware in the head or scalp: shrapnel, surgical clips, or fragments from welding
6. Signs of increased intracranial pressure
* Pregnancy or lactating; note that a negative pregnancy test will be required if the patient is a female in reproductive years
* Estimated IQ less than 80
* Have a sibling or parent with epilepsy
16 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
fengshufang
Fourth Military Medical University, Department of Psychiatry, Xi Jing hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qingrong Tan, Ph.D
Role: STUDY_DIRECTOR
Department of Psychiatry, Xi Jing hospital, Xi'an, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yun chun Chen
Xi'an, Shaanxi, China
Yun chun Chen
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20110526-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.